Amoéba obtains exemptions in the Netherlands for its biocontrol in 2026

Amoéba, a French specialist in microbiological solutions, has obtained two temporary authorizations in the Netherlands for its biofungicide AXPERA. Granted by the CTGB (Technical Committee for Plant Breeding), these two-year exemptions allow trials on several crops, particularly in greenhouses, permitting the consumption of the harvested crops. This market represents a significant opportunity, as the Netherlands is a leader in greenhouse horticulture. The authorizations will cover major crops such as tomatoes, as well as newer ones like potatoes and leeks.

Koppert, a strategic partner of Amoéba, has also received a license to use AXPERA technology, supported by Glastuinbouw Nederland. These initiatives aim to demonstrate the product's effectiveness against persistent diseases such as powdery mildew, while accelerating its validation and adoption in Europe.